Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)
March 29 2021 - 8:29AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT
TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of March 2021 (No. 2)
Commission File Number 001-37846
CELLECT BIOTECHNOLOGY LTD.
(Translation of registrant’s name
into English)
23 Hata’as
Street
Kfar Saba, Israel
44425
(Address of principal
executive offices)
Indicate by check mark whether the registrant
files or will file annual reports under cover Form 20-F or Form 40-F.
Form 20-F ☒ Form
40-F ☐
Indicate by check mark if the registrant
is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):
Indicate by check mark if the registrant
is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):
On March
29, 2021, Cellect Biotechnology Ltd. (the “Company”) issued a press release entitled “Cellect Biotechnology Reports
Fourth Quarter and Full Year 2020 Financial and Operating Results.”
The text appearing under the heading “Fourth
Quarter and Full Year 2020 Financial Results” and the accompanying financial statements included in Exhibit 99.1 to this
Form 6-K are hereby incorporated by reference into the Registrant’s Registration Statements on Form S-8 (Registration Nos.
333-214817, 333-220015, 333-225003 and 333-232230) and on Form F-3 (Registration Nos. 333-219614 and 333-229083).
SIGNATURE
Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned,
thereunto duly authorized.
Date: March 29, 2021
|
CELLECT BIOTECHNOLOGY, LTD.
|
|
|
|
By:
|
/s/ Eyal Leibovitz
|
|
|
Eyal Leibovitz
|
|
|
Chief Financial Officer
|
2
Cellect Biotechnology (NASDAQ:APOP)
Historical Stock Chart
From Apr 2024 to May 2024
Cellect Biotechnology (NASDAQ:APOP)
Historical Stock Chart
From May 2023 to May 2024
Real-Time news about Cellect Biotechnology Ltd (NASDAQ): 0 recent articles
More Cellect Biotechnology Ltd. News Articles